JOSEPH P SLATTERY
CIK 1246530 · EVP and CFO · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$350.5K
Companies
8
Total Filings
95
Lifetime Open-Market Net
-$7.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMA | Director | 16,000 | $5.76 | $92.2K | $95.8K | 3 | 2026-06-18 |
| CVRX | Director | 39,365 | $4.95 | $194.9K | $71.7K | 14 | 2026-06-03 |
| REPL | Director | 11,867 | $5.35 | $63.5K | -$139.2K | 10 | 2026-04-07 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 9,066 | $56.99 | $516.7K | $149.4K | 8 | 2024-06-05 |
| ASENSUS SURGICAL, INC. (TRXC) Delisted | EVP and CFO | 125,000 | $4.08 | $510.0K | -$7.95M | 28 | 2019-05-15 |
| BAXANO SURGICAL, INC. (BAXS) Delisted | Executive V.P. and CFO | 229,571 | — | — | $0 | 1 | 2013-06-04 |
| BAXANO SURGICAL, INC. (TSON) Delisted | Executive V.P. and CFO | 142,994 | — | — | $351.0K | 19 | 2013-03-01 |
| MICROMET, INC. (MITI) Delisted | Director | 0 | — | — | $24.8K | 7 | 2012-03-06 |
Recent Filings · Page 3 of 10
95 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-10 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2022-04-29 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-05 | REPL | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | CVRX | Exer (M) | +11,640 | $3.3K | EDGAR |
| 2021-12-02 | CVRX | Exer (M) | +3,000 | $720 | EDGAR |
| 2021-07-02 | CVRX | Grant (A) | +5,555 | $100.0K | EDGAR |
| 2021-07-01 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-05 | REPL | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.